Tech Company Financing Transactions
Scientia Vascular Funding Round
On 5/28/2021, Scientia Vascular raised $50 million in investment from Vivo Capital.
Transaction Overview
Company Name
Announced On
5/28/2021
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Vivo Capital (Joseph Siletto)
Proceeds Purpose
The financing will be used to accelerate sales, marketing, and new product development in both its core neurovascular stroke market as well as adjacent markets in peripheral vascular and interventional oncology.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3487 W 2100 South 100
West Valley City, UT 84119
USA
West Valley City, UT 84119
USA
Phone
Website
Email Address
Overview
Scientia is a pioneer in microfabrication technology and the company has used their core expertise to create a suite of commercially available and pipeline products for the treatment of neurovascular disease, peripheral vascular disease and interventional oncology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Lippert
Chief Scientific Officer
Clark Davis
VP - Engineering
Ed Snyder
VP - Operations
David Plank
VP - R & D
Todd Turnlund
VP - Regulatory Affairs
David Sabodski
VP - Sales
David Rardin
Browse more venture capital transactions:
Prev: 5/28/2021: Superconductive venture capital transaction
Next: 5/28/2021: BrightHire venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. All VC database entries reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs